Invesco’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,900
Closed -$222K 3914
2020
Q4
$222K Sell
1,900
-1,300
-41% -$143K ﹤0.01% 3514
2020
Q3
$332K Hold
3,200
﹤0.01% 3281
2020
Q2
$294K Hold
3,200
﹤0.01% 3340
2020
Q1
$288K Sell
3,200
-600
-16% -$63.8K ﹤0.01% 3282
2019
Q4
$431K Hold
3,800
﹤0.01% 3311
2019
Q3
$412K Buy
3,800
+200
+6% +$20.9K ﹤0.01% 3325
2019
Q2
$351K Buy
3,600
+1,400
+64% +$128K ﹤0.01% 3443
2019
Q1
$200K Buy
2,200
+1,800
+450% +$161K ﹤0.01% 3622
2018
Q4
$36K Buy
+400
New +$37.4K ﹤0.01% 3725
2017
Q1
Sell
-600
Closed -$43K 3729
2016
Q4
$43K Hold
600
﹤0.01% 3668
2016
Q3
$52K Hold
600
﹤0.01% 3623
2016
Q2
$52K Hold
600
﹤0.01% 3651
2016
Q1
$45K Hold
600
﹤0.01% 3674
2015
Q4
$46K Hold
600
﹤0.01% 3703
2015
Q3
$40K Buy
+600
New +$44.2K ﹤0.01% 3751

Other funds holding MDT

Invesco's MDT Position: Q2 2026 in Review

Invesco increased its Medtronic (MDT) stake by 6.5% in Q2 2026, buying an estimated $88.6M and bringing the position to 17,885,150 shares worth $1.4B. The position accounts for 0.11% of the portfolio, ranked #136.

Invesco first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.56B in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Invesco held 17,885,150 shares of Medtronic worth $1.4B as of Q2 2026.
  • Invesco bought 1,098,152 Medtronic shares in Q2 2026, an estimated $88.6M.
  • Medtronic made up 0.11% of Invesco's portfolio in Q2 2026, its #136 holding.
  • Invesco first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Invesco's Medtronic position peaked at $1.56B in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.